Ospraie-backed Marrone Bio’s new CEO targets rapid revenue growth
Kevin Helash says he expects consolidation among biologicals producers to gather pace in the next 12-24 months, as investors focus on strengthening the sub-sector’s early leaders.
Kevin Helash says he expects consolidation among biologicals producers to gather pace in the next 12-24 months, as investors focus on strengthening the sub-sector’s early leaders.
Copyright PEI Media
Not for publication, email or dissemination